ArticleMolecules (Basel, Switzerland)2023

New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study.

Mariam M Fakhry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.